Trials / Conditions / Multiple Sclerosis Brain Lesion
Multiple Sclerosis Brain Lesion
4 registered clinical trials studyying Multiple Sclerosis Brain Lesion — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumar NCT06065670 | University of California, San Francisco | Phase 1 / Phase 2 |
| Completed | Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent NCT06322342 | Reveal Pharmaceuticals Inc. | Phase 2 |
| Recruiting | Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy NCT05359653 | University of California, San Francisco | Phase 1 / Phase 2 |
| Completed | Artificial Intelligence in Predicting Progression in Multiple Sclerosis Study NCT05426980 | University of Ljubljana | — |